Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFZ.L Regulatory News (PFZ)

  • There is currently no data for PFZ

Form 8.3 - Pfizer Inc

23 Nov 2015 14:56

RNS Number : 6545G
Franklin Resources, Inc
23 November 2015
Β 

FORM 8.3

Β 

IRISH TAKEOVER PANEL

Β 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1967,

TAKEOVER RULES, 2007 (AS AMENDED)

Β 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES

REPRESENTING 1% OR MORE

Β 

Β 

1. KEY INFORMATION

Β 

Name of person dealing (Note 1)

Franklin Resources, Inc.

Company dealt in

Pfizer Inc.

Class of relevant security to which the dealings being disclosed relate (Note 2)

Ordinary Shares

Date of dealing

20 November 2015

Β 

Β 

2. INTERESTS AND SHORT POSITIONS

Β 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Β 

Β 

Β 

Long

Short

Β 

Β 

Number (%)

Number (%)

(1) Relevant securities

Β 

65,132,715 1.06%

Β 

(2) Derivatives (other than options)

Β 

Β 

(3) Options and agreements to purchase/sell

Β 

Β 

Total

Β 

65,132,715 1.06%

Β 

Β 

Β 

Please note: the total share position, since the previous disclosure, includes the transfer in of 290 ordinary shares of discretionary holdings.

Β 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Β 

Class of relevant security:

Β 

Long

Short

Β 

Β 

Number (%)

Number (%)

(1) Relevant securities

Β 

(2) Derivatives (other than options)

Β 

(3) Options and agreements to purchase/sell

Β 

Total

Β 

Β 

3. DEALINGS (Note 4)

Β 

(a) Purchases and sales

Β 

Purchase/sale

Β 

Number of relevant securities

Price per unit (Note 5)

Sale

1,400

32.1800 USD

Β 

(b) Derivatives transactions (other than options transactions)

Β 

Product name,

e.g. CFD

Nature of transaction (Note 6)

Number of relevant securities (Note 7)

Price per unit (Note 5)

Β 

Β 

Β 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Β 

Product name,

e.g. call option

Β 

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise

price

Type, e.g. American, European etc.

Expiry

date

Option money

paid/received per unit (Note 5)

Β 

(ii) Exercising

Β 

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

Β 

Β 

Β 

(d) Other dealings (including transactions in respect of new securities)Β (Note 4)

Β 

Nature of transaction (Note 8)

Β 

Details

Price per unit (if applicable) (Note 5)

Β 

Β 

Β 

Β 

Β 

4. OTHER INFORMATION

Β 

Agreements, arrangements or understandings relating to options or derivatives

Β 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None stated.

Β 

Is a Supplemental Form 8 attached?Β (Note 9) YES

Β 

Β 

SUPPLEMENTALΒ FORMΒ 8

Β 

IRISHΒ TAKEOVERΒ PANEL

Β 

DISCLOSUREΒ UNDERΒ RULEΒ 8.1Β ANDΒ RULEΒ 8.3Β OFΒ THEΒ IRISHΒ TAKEOVERΒ PANELΒ ACT,Β 1997,TAKEOVERΒ RULES,Β 2013

Β 

Β 

Β 

Β 

DETAILSΒ OFΒ OPENΒ POSITIONS

Β 

(ThisΒ formΒ shouldΒ beΒ attachedΒ toΒ FormΒ 8.1(a)Β &Β (b)(i),Β FormΒ 8.1(b)(ii)Β orΒ FormΒ 8.3,Β asΒ appropriate)

Β 

OPENΒ POSITIONSΒ (NoteΒ 1)

Β 

Β 

Product name,

e.g. call option

Written,

or purchased

Number of relevant securities to which the option or derivative relates

Exercise price

(Note 2)

Type, e.g. American, European etc.

Expiry date

Β 

Β 

Β 

Β 

Date of disclosure

23 November 2015

Contact name

Lucrece Le Gal

Telephone number

+1 (954) 762-4258

subsshholder@franklintempleton.com

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ISEUOVSRVOAAUAA
Date   Source Headline
22nd May 201410:47 amRNSForm 8.5 (EPT/RI) Pfizer Inc
22nd May 201410:47 amRNSForm 8.5 (EPT/RI) Pfizer Inc
22nd May 20149:21 amRNSRule 2.10 Announcement
22nd May 20149:14 amBUSForm 8.3 - Pfizer Inc
22nd May 20147:00 amPRNForm 8.3 - Pfizer Inc.
21st May 20145:35 pmRNSForm 8 (DD) - [Pfizer Inc] - Amendment
21st May 20145:28 pmRNSForm 8.5 (EPT/RI) Replacement Pfizer Inc
21st May 20145:23 pmRNSForm 8.5 (EPT/RI) Replacement Pfizer Inc
21st May 20145:22 pmRNSForm 8.5 (EPT/RI) Replacement Pfizer Inc
21st May 20145:13 pmRNSForm 8.5 (EPT/RI) Replacement Pfizer Inc
21st May 20145:09 pmRNSForm 8 (DD) - Pfizer Inc
21st May 20145:08 pmRNSForm 8.5 (EPT/RI) Replacement Pfizer Inc
21st May 20143:44 pmRNSForm 8.3 - Pfizer Inc
21st May 20143:32 pmRNSForm 8.3 - Astrazeneca PLC
21st May 20143:31 pmRNSForm 8.3 - [Pfizer Inc]
21st May 20143:17 pmRNSForm 8.3 -Pfizer Inc
21st May 20143:15 pmRNSForm 8.3 - Pfizer Inc
21st May 20142:57 pmRNSForm 8.3 - [PFIZER INC]
21st May 20142:56 pmRNSForm 8.3 - Pfizer Inc
21st May 20142:46 pmRNSForm 8 (DD) - Pfizer Inc.
21st May 20142:46 pmBUSForm 8.3 - Pfizer Inc.
21st May 20142:42 pmRNSForm 8.3 - Pfizer Inc
21st May 20142:25 pmBUSForm 8.3 - Pfizer Inc
21st May 20141:23 pmRNSForm 8.3 - Pfizer Inc
21st May 20141:22 pmRNSForm 8.3 - AstraZeneca Plc
21st May 201412:35 pmBUSForm 8.3 - Pfizer Inc
21st May 201412:07 pmRNSForm 8.5 (EPT/NON-RI) Amendment
21st May 201411:55 amRNSForm 8.3 - Pfizer Inc.
21st May 201411:49 amRNSReplacement - Form 8 (OPD) (Pfizer)
21st May 201411:49 amRNSReplacement - Form 8 (OPD) (Pfizer)
21st May 201411:40 amRNSForm 8.3 - Pfizer Inc
21st May 201411:37 amRNSForm 8 (DD) - [Pfizer Inc]
21st May 201411:33 amRNSForm 8.5 (EPT/RI)
21st May 201411:29 amRNSRule 2.10 Announcement
21st May 201411:28 amRNSForm 8.5 (EPT/NON-RI)
21st May 201411:22 amRNSForm 8.5 (EPT/RI)
21st May 201411:09 amRNSForm 8.5 (EPT/RI) Pfizer Inc
21st May 201411:08 amRNSForm 8.5 (EPT/RI) Pfizer Inc
21st May 201411:07 amRNSForm 8.5 (EPT/RI) Pfizer Inc
21st May 201411:04 amRNSForm 8.5 (EPT/RI) Pfizer Inc
21st May 201410:32 amRNSRule 2.10 Announcement
21st May 201410:27 amRNSForm 8.3 - Pfizer Inc
21st May 20147:00 amPRNForm 8.3 - Pfizer Inc.
20th May 20146:17 pmRNSCLARIFICATION REGARDING PFIZER STATEMENT
20th May 20145:13 pmRNSForm 8 (DD) - [Pfizer Inc] - Amendment
20th May 20144:54 pmRNSForm 8.5 (EPT/RI) Replacement Pfizer Inc
20th May 20144:31 pmBUSForm 8.3 - Pfizer Inc
20th May 20143:47 pmRNSForm 8.3 - [PFIZER INC]
20th May 20143:36 pmRNSForm 8.3 - Pfizer Inc
20th May 20143:23 pmRNSForm 8.3 - Pfizer Inc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.